NEW YORK, Aug. 18, 2016 /PRNewswire/ -- "Veterinary/Animal Vaccines Market, Product [Porcine, (Companion-Canine), (Livestock-Bovine), Poultry, Aquaculture], Diseases [Rabies, FMD, Swine Influenza, Strangles, Furunculosis], Technology [DNA, Recombinant, Inactivated, Conjugate] - Forecast to 2021"
Increase In Livestock Population And Repeated Breakouts Of Livestock Diseases, Increasing Incidence Of Zoonotic Diseases, Initiatives By Various Government Agencies, Animal Associations, And Leading Players, And The Introduction Of New Vaccine Types To Drive the Growth of Veterinary Vaccine Market
In this market, primary investment opportunities are in emerging and immature markets such as the Middle East, Brazil, Argentina, Mexico, Turkey, China, and India; these are lucrative markets for veterinary vaccines, owing to favorable government initiatives.
The global veterinary vaccines market is poised to reach USD 7.68 billion by 2021 from USD 5.81 billion in 2016, at a CAGR of 5.8% from 2016 to 2021.
The report segments the veterinary vaccines market on the basis of products, diseases, technologies, and region. On basis of products, the veterinary vaccines market is categorized into companion animal vaccines, livestock vaccines, poultry vaccines, porcine vaccines, equine vaccines, aquaculture vaccines, and other animal vaccines. In this market, companion animal vaccines form the fastest-growing product segment, due to the increasing number of zoonotic diseases in the human population and the growing number of pet owners worldwide.
The major animal vaccine production technologies include live attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, recombinant vaccines, and DNA vaccines. The DNA vaccines segment is expected to account for the highest growth of the veterinary vaccines market in 2016, due to innovations in technology and increased public awareness about animal vaccination.